Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
ISCP Council of Governors Annual Meeting
Thursday 21st November @12.00 GMT
Save the Date!
This year´s Council of Governors (CoG) Annual Meeting will be held online on Thursday 21st November 2024 at 12:00 GMT.
This is a very special and important gathering for ISCP Governors, the only Annual Meeting fully dedicated to our society´s Ambassadors, where we discuss ways of collaboration, exchange experiences and ideas, go through ISCP strategy and educational plans, and set goals for the following year. The meeting will be held fully online over Zoom so keep an eye for the invitation with all logistic details coming soon. Mark your calendars and make sure you attend this exciting and highly anticipated meeting!
We look forward to welcoming all our Governors on Thursday 21st November. See you then!
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
The latest additions to our A to Z of CV Pharmacotherapy programme are now available to view in the Webinars On Demand section:
1- Statin’ the source of that pain: Pharmacogenomics As A Preemptive Tool
2- Digitalising Care for Hypertension: One for All, All for One
3- Decongesting the current diuretic landscape in Heart Failure
4-Treating Cardiometabolic Syndromes – What’s The Best Approach?
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Serious cardiovascular events rare after CAR T-cell therapy
Posted on October 07, 2024
A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.The... more
Benefits of finerenone consistent in HF regardless if EF midrange or preserved
Posted on October 07, 2024
New data from the FINEARTS-HF trial show that finerenone improved outcomes in patients with HF compared with placebo across the entire midrange... more
Air pollution, even at low levels, linked to higher ischemic stroke risk in some groups
Posted on October 05, 2024
Exposure to air pollution was linked to higher ischemic stroke incidence among women younger than 65 years and residents of areas with... more
Wegovy shows benefit even in patients with high frailty, obesity-related heart failure
Posted on October 04, 2024
Treatment of obesity-related HF with preserved ejection fraction with semaglutide 2.4 mg improved body weight, physical function and HF symptoms regardless of... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Thomas Kahan
Past President
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more
-
Sang Hong Baek
Board Member
Sang Hong Baek is a Board Member of ISCP and also Governor for the Republic of Korea. ISCP Governors act as representatives for different countries worldwide to encourage local participation and contribute to the ISCP's educational programmes. Past president of the ISCP Professor Sang Hong Baek is Director of Heart... more
-
Pablo Avanzas
Secretary
Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more
-
Alberto Lorenzatti
President
Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more
